Consolidated Statements of Operations (USD $)	12 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
Net sales	$ 7,827,258	$ 16,508,678
Cost of sales	6,866,036	10,068,236
Gross margin	961,222	6,440,442
Operating expenses:
Selling, general and administrative	2,564,637	2,969,956
Engineering, research and development	2,149,591	2,794,478
Total operating expenses	4,714,228	5,764,434
(Loss) income from operations	(3,753,006)	676,008
Other income (expense):
Amortization of debt discount	(129,763)	(53,570)
Amortization of deferred financing costs	(219,662)	(108,321)
Change in fair value of common stock warrants	294,785	10,847
Gain on sales of capital asset	0	500
Proceeds from life insurance policy	0	300,029
Interest income	434	616
Interest expense	(478,939)	(367,410)
Interest expense - related parties	(30,000)	(31,964)
Total other expense	(563,145)	(249,273)
(Loss) income before income taxes	(4,316,151)	426,735
(Benefit) provision for income taxes	(1,543,580)	355,719
Net (loss) income	$ (2,772,571)	$ 71,016
Basic (loss) income per common share (in Dollars per share)	$ (0.98)	$ 0.03
Diluted (loss) income per common share (in Dollars per share)	$ (0.98)	$ 0.02
Weighted average number of shares outstanding
Basic (in Shares)	2,834,257	2,657,279
Diluted (in Shares)	2,834,257	2,717,820